TNDM Q4 2025 Earnings — Tandem Diabetes Care, Inc. Revenue & Financial Results | Market Cap Arena

TNDMTandem Diabetes Care, Inc.

$1B

Q4 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$290M+2.7% YoY

Gross Profit

$167M57.7% margin

Operating Income

$8M2.9% margin

Net Income

-$589,000-0.2% margin

EPS (Diluted)

$-0.01

QoQ Revenue Growth

+16.5%

Cash Flow

Operating Cash Flow

$10M

Free Cash Flow

$3M

Stock-Based Comp.

$20M

Balance Sheet

Total Assets

$881M

Total Liabilities

$726M

Stockholders' Equity

$155M

Cash & Equivalents

$91M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$290M	$283M	+2.7%
Gross Profit	$167M	$157M	+6.4%
Operating Income	$8M	-$582,000	+1525.1%
Net Income	-$589,000	$755,000	-178.0%

Revenue Segments

Supplies and Other

$150M52%

Pump

$140M48%

Geographic Segments

UNITED STATES

$210M72%

Non-US

$80M28%